Treatment of asthma and food allergy with herbal interventions from traditional Chinese medicine

Mount Sinai Journal of Medicine

Volumn 78, Issue 5, 2011, Pages 697-716

  Li, Xiu Min ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

anti asthma herbal medicine intervention; asthma; food allergy; Food Allergy Herbal Formula 2; herbal interventions; traditional Chinese medicine

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT;

ARTICLE; ASTHMA; CHEMICAL COMPOSITION; CHINESE MEDICINE; DRUG MECHANISM; DRUG RESEARCH; FOOD ALLERGY; HERBAL MEDICINE; HUMAN; NONHUMAN; PHYTOCHEMISTRY;

ANIMALS; ASTHMA; COMPLEMENTARY THERAPIES; DRUGS, CHINESE HERBAL; FOOD HYPERSENSITIVITY; HUMANS;

EID: 80052783955     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20294     Document Type: Article

References (118)

1. US Centers, for Disease Control and Prevention, National Center for Health Statistics. Asthma. Updated October 2010. Accessed September 18, 2010.
2. American Academy of Allergy, Asthma & Immunology. Asthma statistics. 2010.
3. Akinbami LJ, Schoendorf KC., Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002; 110 (2 part 1): 315-322. (Pubitemid 34833016)
4. Akinbami LJ, Moorman JE, Garbe PL, et al,. Status of childhood asthma in the United States, 1980-2007. Pediatrics 2009; 123 (suppl 3): S131-S145.
5. Metzger WJ, Hunninghake GW, Richerson HB., Late asthmatic responses: inquiry into mechanisms and significance. Clin Rev Allergy 1985; 3: 145-165.
6. Busse WW, Vrtis RF, Dick EC., The role of viral infections in intrinsic asthma: activation of neutrophil inflammation. Agents Actions Suppl 1989; 28: 41-56.
7. Lemanske RF, Kaliner MA., Late-phase allergic reactions. In:, Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, eds. Allergy: Principles and Practice.St. Louis, MO: Mosby; 1993: 320-361.
8. Pauwels R., The relationship between airway inflammation and bronchial hyperresponsiveness. Clin Exp Allergy 1989; 19: 395-398. (Pubitemid 19201357)
9. Drazen JM, Arm JP, Austen KF., Sorting out the cytokines of asthma. J Exp Med 1996; 183: 1-5. (Pubitemid 26028739)
10. Bousquet J, Jeffery PK, Busse WW, et al,. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720-1745. (Pubitemid 30329053)
11. Elias JA, Zhu Z, Chupp G, et al,. Airway remodeling in asthma. J Clin Invest 1999; 104: 1001-1006.
12. Kumar RK., Understanding airway wall remodeling in asthma: a basis for improvements in therapy? Pharmacol Ther 2001; 91: 93-104. (Pubitemid 33139795)
13. Niimi A, Matsumoto H, Amitani R, et al,. Airway wall thickness in asthma assessed by computed tomography: relation to clinical indices. Am J Respir Crit Care Med 2000; 162 (4 part 1): 1518-1523.
14. Howarth PH., The influence of pharmacological therapy on airway remodeling in asthma. In: Howarth, PH, Wilson, JW, Bousquet, J, Rak, S, Pauwels RA, eds. Airway Remodeling. New York, NY: Marcel Dekker, Inc.; 2001: 167-188.
15. Jeffery PK, Godfrey RW, Adelroth E, et al,. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145 (4 part 1): 890-899.
16. Wilson JW., What causes airway remodelling in asthma? Clin Exp Allergy 1998; 28: 534-536. (Pubitemid 28238266)
17. Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL., Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial. Pediatr Allergy Immunol 2006; 17: 316-322.
18. Christodoulopoulos P, Cameron L, Nakamura Y, et al,. TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J Allergy Clin Immunol 2001; 107: 586-591. (Pubitemid 32397741)
19. Zhang DH, Cohn L, Ray P, et al,. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997; 272: 21597-603. (Pubitemid 27374036)
20. Zheng W, Flavell RA., The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89: 587-596. (Pubitemid 27511769)
21. Zhang T, Srivastava K, Wen MC, Yang N, Cao J, Busse P, et al,. Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma. Phytother Res 2010; 24 (7): 1047-1055.
22. Zhu J, Yamane H, Cote-Sierra J, et al,. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 2006; 16: 3-10. (Pubitemid 43129303)
23. Srivastava K, Zhang T, Yang N, Sampson H, Li XM., Anti-Asthma Simplified Herbal Medicine Intervention-induced long-lasting tolerance to allergen exposure in an asthma model is interferon-gamma, but not transforming growth factor-beta dependent. Clin Exp Allergy 2010; 40 (11): 1678-1688.
24. Srivastava K, Sampson H, Li XM., The Anti-Asthma Chinese Herbal Formula ASHMI Provides More Persistent Benefits than Dexamethasone in a Murine Asthma Model. J Allergy Clin Immunol (Abstract) 2011; 127: AB261.
25. Hall IP., The beta-agonist controversy revisited. Lancet 2004; 363: 183-184.
26. The National Institute of Allergy and Infectious Diseases (NIAID). Asthma and Allergic Diseases Cooperative Research Centers (U19). 2010. Accessed September 19, 2010.
27. Sheth A, Reddymasu S, Jackson R., Worsening of asthma with systemic corticosteroids. J Gen Intern Med 2006; 21: C11-C13.
28. Lipworth BJ., Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 159: 941-955. (Pubitemid 29222495)
29. Roland NJ, Bhalla RK, Earis J., The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004; 126: 213-219. (Pubitemid 38943140)
30. Toogood JH, Crilly RG, Jones G, et al,. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis 1988; 138: 57-61.
31. Packe GE, Robb O, Robins SP, et al,. Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. J R Coll Physicians Lond 1996; 30: 128-132. (Pubitemid 26176231)
32. Zöllner EW., Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)a-the risk as determined by gold standard adrenal function tests: a systematic review. Pediatr Allergy Immunol 2007; 18: 469-474. (Pubitemid 47206740)
33. Fukushima C, Matsuse H, Tomari S, et al,. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003; 90: 646-651. (Pubitemid 36712673)
34. Noonan M, Leflein J, Corren J, et al,. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma. BMC Pediatr 2009; 9: 43.
35. Wang JJ, Rochtchina E, Tan AG, et al,. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology 2009; 116: 652-657.
36. Cordina M, Fenech AG, Vassallo J, et al,. Anxiety and the management of asthma in an adult outpatient population. Ther Adv Respir Dis 2009; 3: 227-233.
37. Bhalla RK, Taylor W, Jones AS, et al,. The inflammation produced by corticosteroid inhalers in the pharynx in asthmatics. Clin Otolaryngol 2008; 33: 581-586.
38. Wang J, Sampson HA., Food allergy. J Clin Invest 2011; 121: 827-835.
39. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107: 191-193. (Pubitemid 32105265)
40. Bock SA, Muñoz-Furlong A, Sampson HA., Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119: 1016-1018. (Pubitemid 46527814)
41. Sicherer SH, Muñoz-Furlong A, Godbold JH, et al,. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010; 125: 1322-1326.
42. Pali-Scholl I, Renz H, Jensen-Jarolim E., Update on allergies in pregnancy, lactation, and early childhood. J Allergy Clin Immunol 2009; 123: 1012-1021.
43. Worth A, Sheikh A., Food allergy and atopic eczema. Curr Opin Allergy Clin Immunol 2010; 10: 226-230.
44. Björkstén B., Genetic and environmental risk factors for the development of food allergy. Curr Opin Allergy Clin Immunol 2005; 5: 249-253. (Pubitemid 40694991)
45. Prescott SL, Clifton V., Asthma and pregnancy: emerging evidence of epigenetic interactions in utero. Curr Opin Allergy Clin Immunol 2009; 9: 417-426.
46. Van PN, Le GG, McConnell MJ., Epigenetic regulation of Th2 cytokine expression in atopic diseases. Tissue Antigens 2008; 72: 91-97. (Pubitemid 352009808)
47. Nelson HS, Lahr J, Rule R, et al,. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99: 744-751. (Pubitemid 27280363)
48. Oppenheimer JJ, Nelson HS, Bock SA, et al,. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90: 256-262.
49. Blumchen K, Ulbricht H, Staden U, et al,. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126: 83-91.
50. Clark AT, Islam S, King Y, et al,. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64: 1218-1220.
51. Jones SM, Pons L, Roberts JL, et al,. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124: 292-300.
52. Varshney P, Steele PH, Vickery BP, et al,. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009; 124: 1351-1352.
53. Sicherer SH, Sampson HA., Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med 2009; 60: 261-277.
54. Plaut M, Sawyer RT, Fenton MJ., Summary of the 2008 National Institute of Allergy and Infectious Diseases-US Food and Drug Administration Workshop on Food Allergy Clinical Trial Design. J Allergy Clin Immunol 2009; 124: 671-678.
55. Leung DY, Sampson HA, Yunginger JW, et al,. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348: 986-993. (Pubitemid 36302243)
56. Slader CA, Reddel HK, Jenkins CR, et al,. Complementary and alternative medicine use in asthma: who is using what? Respirology 2006; 11: 373-387. (Pubitemid 43824333)
57. Sawni A, Thomas R., Pediatricians' attitudes, experience and referral patterns regarding Complementary/ Alternative Medicine: a national survey. BMC Complement Altern Med 2007; 7: 18.
58. Mark JD., Integrative medicine and asthma. Pediatr Clin North Am 2007; 54: 1007-1023. (Pubitemid 350179895)
59. US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Botanical Drug Products. Updated June 2004.
60. National Center for Complementary and Alternative Medicine. 28, 2008.
61. Li XM., Complementary and alternative medicine in pediatric allergic disorders. Curr Opin Allergy Clin Immunol 2009; 9 (2): 161-167.
62. Jindal V, Ge A, Mansky PJ., Safety and efficacy of acupuncture in children: a review of the evidence. J Pediatr Hematol Oncol 2008; 30: 431-442.
63. Hon KL, Leung TF, Ng PC, et al,. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007; 157: 357-363. (Pubitemid 47083830)
64. Wen MC, Wei CH, Hu ZQ, et al,. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol 2005; 116: 517-524.
65. Chang TT, Huang CC, Hsu CH., Clinical evaluation of the Chinese herbal medicine formula STA-1 in the treatment of allergic asthma. Phytother Res 2006; 20: 342-347.
66. Busse PJ, Schofield B, Birmingham N, et al,. The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice. Ann Allergy Asthma Immunol 2010; 104: 236-246.
67. Miranda C, Busacker A, Balzar S, et al,. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004; 113: 101-108. (Pubitemid 38096168)
68. Ariano R, Panzani RC, Augeri G., Late onset asthma clinical and immunological data: importance of allergy. J Investig Allergol Clin Immunol 1998; 8: 35-41. (Pubitemid 28143378)
69. Quadrelli SA, Roncoroni AJ., Is asthma in the elderly really different? Respiration 1998; 65: 347-353. (Pubitemid 28491269)
70. Huang X, Kong L, Li X, et al,. Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 812: 71-84. (Pubitemid 39535402)
71. Efferth T, Kahl S, Paulus K, et al,. Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells. Mol Cancer Ther 2008; 7: 152-161.
72. Zhang HY, Hu CX, Liu CP, et al,. Screening and analysis of bioactive compounds in traditional Chinese medicines using cell extract and gas chromatography-mass spectrometry. J Pharm Biomed Anal 2007; 43: 151-157. (Pubitemid 44856207)
73. Ehrman TM, Barlow DJ, Hylands PJ., Phytochemical databases of Chinese herbal constituents and bioactive plant compounds with known target specificities. J Chem Inf Model 2007; 47: 254-263. (Pubitemid 46615931)
74. Ehrman TM, Barlow DJ, Hylands PJ., Phytochemical informatics of traditional Chinese medicine and therapeutic relevance. J Chem Inf Model 2007; 47: 2316-2334. (Pubitemid 350275098)
75. Matsui S, Sonoda Y, Sekiya T, et al,. Glycyrrhizin derivative inhibits eotaxin 1 production via STAT6 in human lung fibroblasts. Int Immunopharmacol 2006; 6: 369-375. (Pubitemid 43120451)
76. Matsui S, Matsumoto H, Sonoda Y, et al,. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line. Int Immunopharmacol 2004; 4: 1633-1644. (Pubitemid 39348861)
77. Conroy DM, Williams TJ., Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2001; 2: 150-156. (Pubitemid 34187921)
78. Sato E, Haniuda M, Numanami H, et al,. Histamine and serotonin stimulate eotaxin production by a human lung fibroblast cell line. Int Arch Allergy Immunol 2002; 128 (suppl 1): 12-17. (Pubitemid 34639012)
79. Jayaprakasam B, Doddaga S, Wang R, et al,. Licorice flavonoids inhibit eotaxin-1 secretion by human fetal lung fibroblasts in vitro. J Agric Food Chem 2009; 57: 820-825.
80. Patil SP, Jayaprakasam B, Bezdecny S, et al,. Anti-inflammatory effects of a purified herbal flavonoid 7, 4a-dihydroxyflavone in vivoand in a murine model [abstract]. J Allergy Clin Immunol 2009; 123 (suppl): S122.
81. Yang N, Zhu-ge J, Zhang W, et al,. Flavonoids from gan-cao (Radix glycerrhizae) inhibit Th2 memory cell cytokine production [abstract]. J Allergy Clin Immunol 2010; 125 (suppl 1): Abstract 198.
82. Deshmukh VM, Toelle BG, Usherwood T, et al,. The association of comorbid anxiety and depression with asthma-related quality of life and symptom perception in adults. Respirology 2008; 13: 695-702. (Pubitemid 351977582)
83. Di MF, Verga M, Santus P, et al,. Close correlation between anxiety, depression, and asthma control. Respir Med 2010; 104: 22-28.
84. Eisner MD, Katz PP, Lactao G, et al,. Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 2005; 94: 566-574. (Pubitemid 40712781)
85. Kovacs M, Stauder A, Szedmak S., Severity of allergic complaints: the importance of depressed mood. J Psychosom Res 2003; 54: 549-557. (Pubitemid 38367947)
86. Lavoie KL, Bacon SL, Barone S, et al,. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 2006; 130: 1039-1047. (Pubitemid 44583733)
87. Thomas M, Price D., Impact of comorbidities on asthma. Expert Rev Clin Immunol 2008; 4: 731-742.
88. Oraka E, King ME, Callahan DB., Asthma and serious psychological distress: prevalence and risk factors among US adults, 2001-2007. Chest 2010; 137: 609-616.
89. McGrady ME, Cotton S, Rosenthal SL, et al,. Anxiety and asthma symptoms in urban adolescents with asthma: the mediating role of illness perceptions. J Clin Psychol Med Settings 2010; 17: 349-356.
90. Liang B, Slotkin T, Yang N, et al,. Inhibitory effect of sub-fractions containing mainly flavonoids in KuShen (Radix sophorae flavescentis) on airway smooth muscle contraction [abstract]. J Allergy Clin Immunol 2011; 127 (suppl): AB67.
91. World Health Organization. Monographs on selected medicinal plants, volume 1: Radix Glycyrrhizae. Geneva: World Health Organization; 1999: 183-194.
92. Peirce A., The American Pharmaceutical Association Practical Guide to Natural Medicines. New York, NY: William Morrow & Co., Inc.; 1999.
93. Kelly-Pieper K, Patil SP, Busse P, et al,. Safety and tolerability of an antiasthma herbal formula (ASHMI) in adult asthmatics: a randomized, double-blinded, placebo-controlled, dose escalation phase I study. J Altern Complement Med 2009; 15: 735-743.
94. Busse P, Srivastava K, et al,. Safety, tolerability and beneficial immunological responses of complementary ASHMI therapy to inhaled corticosteroids therapy in children with persistent allergic asthma with or without allergic rhinitis. Allergy Clin Immunol (Abstract) 2010; 125 (2): S199.
95. Patil SP, Ji WJ, Singha A, et al,. In vitro immunomodulatory effect of ASHMI (Anti-asthma Herbal Medicine Intervention) on PBMCs from asthmatics [abstract]. J Allergy Clin Immunol 2010; 125 (suppl 1): AB198.
96. Bensky D, Barolet R., Chinese Herbal Medicine: Formulas & Strategies. Seattle, WA: Eastland Press; 1990.
97. Li XM, Zhang TF, Huang CK, et al,. Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 2001; 108: 639-646.
98. The State Pharmacopoeia Commission of The People's Republic of China. Pharmacopoeia of the People's Republic of China. 6 ed. People's Medical Publishing House; 2005.
99. Kattan JD, Srivastava KD, Zou ZM, et al,. Pharmacological and immunological effects of individual herbs in the Food Allergy Herbal Formula-2 (FAHF-2) on peanut allergy. Phytother Res 2008; 22: 651-659. (Pubitemid 351716554)
100. Srivastava KD, Kattan JD, Zou ZM, et al,. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 2005; 115: 171-178. (Pubitemid 40075439)
101. Qu C, Srivastava K, Ko J, et al,. Induction of tolerance after establishment of peanut allergy by the Food Allergy Herbal Formula-2 is associated with up-regulation of interferon-gamma. Clin Exp Allergy 2007; 37: 846-855. (Pubitemid 47074550)
102. Srivastava KD, Qu C, Zhang T, et al,. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN- gamma-producing CD8+ T cells. J Allergy Clin Immunol 2009; 123: 443-451.
103. Yang N, Zhang J, Smapson H, Li X-M., Immunopharmacological effect of Butonal-extracted Food Allergy Herbal Formula 2 (FAFH2) and its sub-fractions on IgE and TNF-α production. J Allergy Clin Immunol (abstract) 2010; 123 (2): S182.
104. Ebo DG, Hagendorens MM, Schuerwegh AJ, et al,. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy. Cytometry B Clin Cytom 2007; 72: 196-203. (Pubitemid 46676752)
105. Kahlert H, Suck R, Weber B, et al,. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy. Int Arch Allergy Immunol 2008; 145: 193-206. (Pubitemid 351301311)
106. Nagao M, Hiraguchi Y, Hosoki K, et al,. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol 2008; 146 (suppl 1): 47-53.
107. Wanich N, Nowak-Wegrzyn A, Sampson HA, et al,. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009; 123: 789-794.
108. Larsen F, Hanifin JM., Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002; 22: 1-24. (Pubitemid 34137417)
109. Laughter D, Istvan JA, Tofte SJ, et al,. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000; 43: 649-655.
110. Eigenmann PA, Sicherer SH, Borkowski TA, et al,. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101: E8.
111. Wisniewski J, Oh M, Nowak-WÈgrzyn A, et al,. Efficacy and safety of traditional Chinese medicine for treatment of atopic dermatitis (AD) [abstract]. J Allergy Clin Immunol 2010; 123: S37.
112. Zhang T, Srivastava K, Wen MC, et al,. Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma. Phytother Res 2010; 24: 1047-1055.
113. Srivastava K, Zhang T, Yang N, et al,. Anti-Asthma Simplified Herbal Medicine Intervention-induced long-lasting tolerance to allergen exposure in an asthma model is interferon-gamma, but not transforming growth factor-beta dependent. Clin Exp Allergy 2010; 40: 1678-1688.
114. Chuang Y, Liu C, Yang N, et al,. Inhibitory effect of constituents isolated from Ganoderma lucidum on LPS-stimulated macrophage cells TNF-α production [abstract]. J Allergy Clin Immunol 2011; 127 (suppl): AB87.
115. Alban J, Patil SP, Li X., Flavonoids in ASHMI (Anti-asthma Herbal Medicine Intervention) inhibit microglial cell TNF-α secretion [abstract]. J Allergy Clin Immunol 2010; 125 (suppl): AB206.
116. Slotkin T, Liang B, Yang N, Li X-M., Inhibitory Effect of Formononetin Isolated from Ku Shen (Radix Sophorae Flavescentis) on IgE production of B cells. J Allergy Clin Immunol (Abstract) 2011; 127: AB262.
117. Wang J, Patil S, Yang N, et al,. Safety, tolerability, and immunologic effects of a food allergy herbal formula (FAHF-2) in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation phase I study. Ann Allergy Asthma Immunol 2010; 105: 75-84.
118. Patil SP, Wang J, Song Y, et al,. Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study. J Allergy Clin Immunol 2011; July 25. [Epub ahead of print].